Wave 3 CCGs given go ahead

pharmafield logo - pharma news

CCG News The NHS Commissioning Board (NHS CB) has backed all 62 clinical commissioning groups in the third wave of its authorisation process to take on new their responsibilities from 1 April 2013.

Six CCGs were authorised without any conditions but five groups will be given intensive support in their development after concerns were raised. The remaining 56 CCGs were authorised with conditions.

The completion of the third authorisation wave means that 163 of the 211 CCGs across England have now been given the green light to take on their new commissioning responsibilities. From 1 April 2013, CCGs will be responsible for £65bn to commission local health services.

Dame Barbara Hakin, NHS CB National Director: Commissioning Development, said that the “majority of CCGs are now authorised and up-and-running”.

The five CCGs which were singled out for concern are NHS Eastbourne, Hailsham and Seaford CCG, NHS Newham CCG, NHS Herefordshire CCG, NHS Scarborough and Ryedale CCG and NHS Vale of York CCG. The NHS CB said these groups will still be able to take control of their individual commissioning budgets but will be given “intensive support”.

Issues raised by the board include the clear and credible integrated plans of NHS Eastbourne, Hailsham and Seaford CCG, NHS Herefordshire CCG, NHS Scarborough and Ryedale CCG and NHS Vale of York, plus the financial systems and processes used by NHS Newham CCG.

The remaining 48 CCGs are set to authorised next month.